Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 23, 2018
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
[ Thu, Aug 23rd 2018
] - WOPRAI
Wed, August 22, 2018
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
Jason Gerberry Maintained (ABBV) at Strong Buy with Increased Target to $107 on, Aug 22nd, 2018
Jason Gerberry of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $105 to $107 on, Aug 22nd, 2018.
Jason has made no other calls on ABBV in the last 4 months.
There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 0 agree with Jason's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jason
- David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $130 on, Monday, June 11th, 2018
- Vamil Divan of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $89 on, Wednesday, May 30th, 2018
- Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018
